Literature DB >> 23422749

Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.

Rossana Trotta1, Li Chen, Stefan Costinean, Srirama Josyula, Bethany L Mundy-Bosse, David Ciarlariello, Charlene Mao, Edward L Briercheck, Kathleen K McConnell, Anjali Mishra, Lianbo Yu, Carlo M Croce, Michael A Caligiuri.   

Abstract

It is known that microRNAs (miRs) are involved in lymphocyte development, homeostasis, activation, and occasionally malignant transformation. In this study, a miR-155 transgene (tg) was driven to be overexpressed off of the lck promoter in order to assess its effects on natural killer (NK) cell biology in vivo. miR-155 tg mice have an increase in NK-cell number with an excess of the CD11b(low)CD27(high) NK subset, indicative of a halt in terminal NK-cell differentiation that proved to be intrinsic to the cell itself. The increase in NK cells results, in part, from improved survival in medium alone and enhanced expansion with endogenous or exogenous interleukin 15. Phenotypic and functional data from miR-155 tg NK cells showed constitutive activation and enhanced target cell conjugation, resulting in more potent antitumor activity in vitro and improved survival of lymphoma-bearing mice in vivo when compared with wild type NK cells. The enhanced NK-cell survival, expansion, activation, and tumor control that result from overexpression of miR-155 in NK cells could be explained, in part, via diminished expression of the inositol phosphatase SHIP1 and increased activation of ERK and AKT kinases. Thus, the regulation of miR-155 is important for NK-cell development, homeostasis, and activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23422749      PMCID: PMC3630828          DOI: 10.1182/blood-2012-12-467597

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  In vivo developmental stages in murine natural killer cell maturation.

Authors:  Sungjin Kim; Koho Iizuka; Hyun-Seok P Kang; Ayotunde Dokun; Anthony R French; Suellen Greco; Wayne M Yokoyama
Journal:  Nat Immunol       Date:  2002-05-13       Impact factor: 25.606

Review 2.  The dynamic life of natural killer cells.

Authors:  Wayne M Yokoyama; Sungjin Kim; Anthony R French
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

3.  CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity.

Authors:  Yoshihiro Hayakawa; Mark J Smyth
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

4.  Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.

Authors:  W E Thierfelder; J M van Deursen; K Yamamoto; R A Tripp; S R Sarawar; R T Carson; M Y Sangster; D A Vignali; P C Doherty; G C Grosveld; J N Ihle
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

5.  BCR/ABL activates mdm2 mRNA translation via the La antigen.

Authors:  Rossana Trotta; Tatiana Vignudelli; Olivia Candini; Robert V Intine; Luisa Pecorari; Clara Guerzoni; Giorgia Santilli; Mike W Byrom; Silvia Goldoni; Lance P Ford; Michael A Caligiuri; Richard J Maraia; Danilo Perrotti; Bruno Calabretta
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

6.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

7.  Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.

Authors:  Jia-Wang Wang; Julie M Howson; Tomar Ghansah; Caroline Desponts; John M Ninos; Sarah L May; Kim H T Nguyen; Noriko Toyama-Sorimachi; William G Kerr
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

8.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

Authors:  X Cao; E W Shores; J Hu-Li; M R Anver; B L Kelsall; S M Russell; J Drago; M Noguchi; A Grinberg; E T Bloom
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

9.  In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.

Authors:  Megan A Cooper; Jennifer E Bush; Todd A Fehniger; Jeffrey B VanDeusen; Ross E Waite; Yang Liu; Hector L Aguila; Michael A Caligiuri
Journal:  Blood       Date:  2002-07-05       Impact factor: 22.113

10.  Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells.

Authors:  S Shresta; D M MacIvor; J W Heusel; J H Russell; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  29 in total

1.  The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.

Authors:  Wang-Yang Chen; Xiao-Juan Zhao; Zhi-Fu Yu; Fu-Lan Hu; Yu-Peng Liu; Bin-Bin Cui; Xin-Shu Dong; Ya-Shuang Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1.

Authors:  Serkan Belkaya; Sean E Murray; Jennifer L Eitson; M Teresa de la Morena; James A Forman; Nicolai S C van Oers
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

Review 3.  MicroRNAs in allergy and asthma.

Authors:  Ana Rebane; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

Review 4.  microRNA management of NK-cell developmental and functional programs.

Authors:  Jeffrey W Leong; Ryan P Sullivan; Todd A Fehniger
Journal:  Eur J Immunol       Date:  2014-09-16       Impact factor: 5.532

5.  MicroRNA-29b mediates altered innate immune development in acute leukemia.

Authors:  Bethany L Mundy-Bosse; Steven D Scoville; Li Chen; Kathleen McConnell; Hsiaoyin C Mao; Elshafa H Ahmed; Nicholas Zorko; Sophia Harvey; Jordan Cole; Xiaoli Zhang; Stefan Costinean; Carlo M Croce; Karilyn Larkin; John C Byrd; Sumithira Vasu; William Blum; Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  J Clin Invest       Date:  2016-10-24       Impact factor: 14.808

6.  MicroRNA-155 Deficiency Exacerbates Trypanosoma cruzi Infection.

Authors:  Bijay K Jha; Sanjay Varikuti; Abhay R Satoskar; Bradford S McGwire; Gabriella R Seidler; Greta Volpedo
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

7.  PTEN is a negative regulator of NK cell cytolytic function.

Authors:  Edward L Briercheck; Rossana Trotta; Li Chen; Alex S Hartlage; Jordan P Cole; Tyler D Cole; Charlene Mao; Pinaki P Banerjee; Hsiang-Ting Hsu; Emily M Mace; David Ciarlariello; Bethany L Mundy-Bosse; Isabel Garcia-Cao; Steven D Scoville; Lianbo Yu; Robert Pilarski; William E Carson; Gustavo Leone; Pier Paolo Pandolfi; Jianhua Yu; Jordan S Orange; Michael A Caligiuri
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 8.  Mini but mighty: microRNAs in the pathobiology of periodontal disease.

Authors:  Moritz Kebschull; Panos N Papapanou
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

Review 9.  Transcriptional and post-transcriptional regulation of NK cell development and function.

Authors:  Jeffrey W Leong; Julia A Wagner; Aaron R Ireland; Todd A Fehniger
Journal:  Clin Immunol       Date:  2016-03-03       Impact factor: 3.969

10.  MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways.

Authors:  Ryan P Sullivan; Leslie A Fogel; Jeffrey W Leong; Stephanie E Schneider; Rachel Wong; Rizwan Romee; To-Ha Thai; Veronika Sexl; Scot J Matkovich; Gerald W Dorn; Anthony R French; Todd A Fehniger
Journal:  J Immunol       Date:  2013-11-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.